The Effect of Pomegranate (Punica Granatum L.) Peel Compress Application on Pain and Physical Function Status

NCT06034106 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2023-09-13

No results posted yet for this study

Summary

Osteoarthritis is the most common type of arthritis among rheumatologic diseases. Complementary therapies are one of the effective methods for pain control. This study was planned as a randomized controlled experimental study. For this purpose, patients diagnosed with knee osteoarthritis who applied to the Orthopedics Outpatient Clinic will be included. It was calculated that the study would include at least 67 patients. The study will be collected using patient information form, descriptive characteristics form, Visual Analog Scale (VAS) and WOMAC osteoarthritis application scale. It was planned as a randomized controlled experimental study to evaluate the effect of pomegranate peel (P. granatum) compress application on pain and function status. The study was divided into 3 groups as Pomegranate (Punica granatum) peel compress, hot compress and control group. Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.

Conditions

  • Pomegranate (P. Granatum) Peel Compress

Interventions

BEHAVIORAL

Pomegranate (Punica granatum) peel compress

Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.

BEHAVIORAL

Hot compress

Hot compress was applied 3 days a week for 3 weeks.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • DİLEK EFE ARSLAN · ERCİYES UNİVERSİTY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-14
Primary Completion
2023-09-30
Completion
2023-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06034106 on ClinicalTrials.gov